Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study

Sunil Kumar Kota, Siva Krishna Kota, Sruti Jammula, Lalit Kumar Meher, Sandip Panda, Prabhas Rranjan Tripathy, Kirtikumar D Modi, Sunil Kumar Kota, Siva Krishna Kota, Sruti Jammula, Lalit Kumar Meher, Sandip Panda, Prabhas Rranjan Tripathy, Kirtikumar D Modi

Abstract

Background: Elevated renin-angiotensin-aldosterone system (RAAS) activity is an important mechanism in the development of hypertension. Both obesity and 25-hydroxy vitamin D [25(OH)D] deficiency have been associated with hypertension and augmented renin-angiotensin system (RAS) activity. We tried to test the hypothesis that vitamin D deficiency and obesity are associated with increased RAS activity in Indian patients with hypertension.

Materials and methods: Fifty newly detected hypertensive patients were screened. Patients with secondary hypertension, chronic kidney disease, or coronary artery disease were excluded. Patients underwent measurement of vitamin D and plasma renin and plasma aldosterone concentrations. They were divided into three groups according to their baseline body mass index (BMI; normal <25 kg/m(2), overweight 25-29.9 kg/m(2) and obese ≥30 kg/m(2)) and 25(OH)D levels (deficient <20 ng/ml, insufficient 20-29 ng/ml and optimal ≥30 ng/ml).

Results: A total of 50 (male:female - 32:18) patients were included, with a mean age of 49.5 ± 7.8 years, mean BMI of 28.3 ± 3.4 kg/m(2) and a mean 25(OH)D concentration of 18.5 ± 6.4 ng/ml. Mean systolic blood pressure (SBP) was 162.4 ± 20.2 mm Hg and mean diastolic blood pressure (DBP) was 100.2 ± 11.2 mm Hg. All the three blood pressure parameters [SBP, DBP and mean arterial pressure (MAP)] were significantly higher among individuals with lower 25(OH)D levels. The P values for trends in SBP, DBP and MAP were 0.009, 0.01 and 0.007, respectively. Though all the three blood pressure parameters (SBP, DBP and MAP) were higher among individuals with higher BMIs, they were not achieving statistical significance. Increasing trends in PRA and PAC were noticed with lower 25(OH)D and higher BMI levels.

Conclusion: Vitamin D deficiency and obesity are associated with stimulation of RAAS activity. Vitamin D supplementation along with weight loss may be studied as a therapeutic strategy to reduce tissue RAS activity in individualswith Vitamin D deficiency and obesity.

Keywords: Hypertension; obesity; renin–angiotensin–aldosterone system; vitamin D.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Mean arterial pressure in patients as per their serum vitamin D levels
Figure 2
Figure 2
Mean arterial pressure in patients as per their body mass index

References

    1. Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, Zonderman AB. Associations amonmg 25-Hydroxyvitamin D, Diet quality and metabolic disturbance differ by adiposity in United State Adults. J Clin Endocrinol Metab. 2010;95:814–27.
    1. Luft F. The Renin, Angiotensin, Aldosterone and Obesity connection. J Mol Med. 2010;88:861–4.
    1. Yvan-Charvet L, Quignard-Boulange A. Role of adipose tissue rennin-angiotensin system in metabolic and ingflammatory diseases associated with obesity. Kidney Int. 2010;79:162–8.
    1. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium independent and 1,25(OH)2(D)3-dependent regulation of the rennin-angiotensin system in 1 α hydroxylase knock out mice. Kidney Int. 2008;73:163–71.
    1. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig. 2002;110:229–38.
    1. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008;74:170–9.
    1. Kong J, Qiao G, Zhang Z, Liu SQ, Li YC. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses rennin expression independent of parathyroid hormone and calcium. Kidney Int. 2008;74:1577–81.
    1. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Chem Biol. 2007;282:29821–30.
    1. Resnick LM, Muller Fb, Laragh JH. Calcium regulating hormones in essential hypertension.Relation to plasma rennin activity and sodium metabolism. Ann Intern Med. 1986;105:649–54.
    1. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al. Independent association between 1, 25 dihydroxyvitamin D and the rennin-angiotensin system.The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta. 2010;411:17–8.
    1. Dluhy RG, Williams GH. Aldosterone-villain or bystander? N Engl J Med. 2004;351:8–10.
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
    1. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72–5.
    1. Duprez D, de Buyzere M, de Backer T, Clement D. Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension. Blood Press. 1994;3:389–93.
    1. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52:828–32.
    1. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9.
    1. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008;57:2619–25.
    1. Gannage-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160:965–71.
    1. Burgess ED, Hawkins RG, Watanabe M. Interaction of 1,25- dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens. 1990;3:903–5.
    1. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25:320–5.
    1. Forman JP, Williams JS, Fisher ND. Plasma 25-Hydroxyvitamin D and Regulation of the Renin- Angiotensin System in Humans. Hypertension. 2010;55:1283–8.
    1. Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto FL, Wong KE, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. Am J Physiol Renal Physiol. 2009;296:F1212–8.
    1. Li J, Brasier AR. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol. 1996;10:252–64.
    1. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol. 2004;15:1805–15.
    1. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab. 1998;83:3925–9.
    1. Kahonen M, Nappi S, Jolma P, Hutri-Kahonen N, Tolvanen JP, Saha H, et al. Vascular influences of calcium supplementation and vitamin D-induced hypercalcemia in NaCl hypertensive rats. J Cardiovasc Pharmacol. 2003;42:319–28.
    1. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, et al. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007;18:613–20.
    1. Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2008;295:H289–96.
    1. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995;15:5789–99.
    1. D’Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3: Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest. 1998;101:252–62.
    1. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol. 2005;97:93–101.
    1. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28:1228–30.
    1. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30:1549–55.
    1. D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–38.
    1. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89(90):387–92.
    1. Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol. 2007;18:1796–806.
    1. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2008;73:163–71.
    1. Vaidya A, Forman JP, Underwood PC, Hopkins PN, Williams GH, Pojoga LH, et al. Th e influence of Body Mass Index and Renin- Angiotensin-Aldostterone System Activity on the Relationship between 25-Hydroxyvitamin D and Adiponectin in Caucasian Men. Eur J Endocrinol. 2011;164:995–1002.
    1. Krikken JA, Dallinga-Thie GM, Navis G, Dullaart RP. Short term dietary sodium restriction decreases HDL cholesterol, apolipoprotein A-I and high molecular weight adiponectin in healthy young men: Relationships with renal hemodynamics and RAAS activation. Nutr Metab Cardiovasc Dis. 2010 [In Press]
    1. Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH, et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab. 2007;92:1821–6.
    1. Kim S, Soltani-Bejnood M, Quignard-Boulange A, Massiera F, Teboul M, Ailhaud G, et al. The Adipose Renin-Angiotensin System Modulates Systemic markers of Insulin Sensitivity and Activates Intrarenal Renin-Angiotensin System. J Biomed Biotechnol. 2006;2006:27012.
    1. Engeli S, Boschmann M, Frings P, Beck L, Janke J, Titze J, et al. Influence of Salt Intake on Renin-Angiotensin and Natriuretic Peptide System Genes in Human Adipose Tissue. Hypertension. 2006;48:1103–8.
    1. Vaidya A, Forman JP. Vitamin D and Hypertension: Current evidence and future directions. Hypertension. 2010;56:774–9.
    1. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–9.
    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
    1. Norman AW. Minireview: Vitamin D receptor–new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.
    1. Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapidresponse signaling. Sci Signal. 2009;2:re4.
    1. Wark JD, Larkins RG, Eisman JA, Wilson KR. Regulation of 25-hydroxy-vitamin D-1 a-hydroxylase in chick isolated renal tubules: Effects of prostaglandin E2, frusemide and acetylsalicylic acid. Clin Sci (Lond) 1981;61:53–9.
    1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis Int. 2009;20:1807–20.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel